Plasma Cell Disorders Meeting 2019
This is a clinically oriented lecture with the intention of allowing oncologists and other cancer health care providers to learn more about the biology and diagnostics of Plasma Cell Disorders and the latest innovations in treating them.
Target Audience
Hematological oncologists, clinical oncologists, and other cancer healthcare providers, including NPs, PAs, and RNs.
Educational Objectives
Following this program, participants should be able to:
- Discuss the basics of and the treatment options for myeloma bone disease.
- Describe the newly-available techniques for diagnostics and treatment monitoring.
- Appraise the potential of novel agents and drug combinations in early clinical trials.
- Better manage the short and long-term side effects of cellular therapies.
- Assess and interpret information about the indication, risks and benefits of novel cellular therapies, and how to obtain guidance regarding any treatment selection.
In this lecture Maximilian Merz, MD, looks at the criteria of diagnostics for myeloma disease as well as available treatments.
Mapping the Battlefield: Imaging of Multiple Myeloma
Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.
Chief of Myeloma, Professor of Oncology
Getting Out the Big Guns: Transplant and Cellular Therapy
Phillip McCarthy, MD, discusses autologous stem cell transplant/rescue following induction therapy, available therapies, and why a majority of patients will have progressive disease.
Professor of Oncology and Internal Medicine
Director, Transplant & Cellular Therapy Center, Department of Medicine
Director, Transplant & Cellular Therapy Center, Department of Medicine
Kelvin Lee, MD, gives a “philosophical talk” regarding novel treatment approaches in myeloma. This lecture helps illustrate the way doctors think about drugs and treatments for treating myeloma.
Caring for the Wounded: Treatment of Myeloma Bone Disease 1
Ryan Hare, PharmD, discusses the treatment of Myeloma Bone Disease. This lecture will review the myeloma bone microenvironment, discuss bone preservation benefits of treatments, describe aniti-myeloma properties, and highlight medication ...
Clinical Pharmacist
Caring for the Wounded: Treatment of Myeloma Bone Disease 2
Hillary Jacobson, DPT, shares the importance of exercise in reducing fatigue in patients diagnosed with cancer.
Physical Therapist
BROADCASTMED